20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-
UNII ERB4JS2WQJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 20-carboxy-23-hydroxy-11-oxo-30-norolean-12-en-3-yl 2-o-.beta.-d-glucopyranuronosyl-.alpha.-d-glucopyranosiduronic Acid, (3.beta.,4.beta.,20.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ERB4JS2WQJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 215720-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C42H62O17 WBQVRPYEEYUEBQ-TYGSXCDJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 20-carboxy-23-hydroxy-11-oxo-30-norolean-12-en-3-yl 2-o-.beta.-d-glucopyranuronosyl-.alpha.-d-glucopyranosiduronic Acid, (3.beta.,4.beta.,20.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.